Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 29 for “"Neuroendocrine differentiation"”.
-
Regulation of the physiological consequences of neuroendocrine differentiation in prostate cancer by kinase and phosphatase cross talk
… effective therapy for this form of the disease. Neuroendocrine (NE) cells are post-mitotic, secretory cells found distributed throughout both normal and malignant prostate tissue. Increased NE cell content is associated with hormone refractory disease, and it is suspected that these NE cells play …
-
Characterization of Gene Expression During Adenosine 3':5'-Cyclic Monophosphate Induced Neuroendocrine Differentiation in Human Prostatic Adenocarcinoma
… transduction pathway can induce reversible neuroendocrine differentiation. Elucidation of those genes that are differentially expressed between undifferentiated prostate cancer cells and prostate cancer cells that have been induced to differentiate may present new insights for the molecular …
-
Grk3 Connects Angiogenesis and Neuroendocrine Differentiation In Prostate Cancer By Activating Hdac2 That Epigenetically Represses Tsp1 and Rest
… cause of mortality in men in the United States. Neuroendocrine prostate cancer (NEPC) is the aggressive subset of castration-resistant prostate cancer (CRPC), found in ~20% lethal CRPC. The mechanisms underlying the progression of PCa to NEPC are still largely unclear, and new drug targets are …
-
Adenocarcinoma-neuroendocrine Transition Of Androgen Resistant PCa Depends On SPARC Down-regulation In Stromal Accessory Cells
Adenocarcinoma-neuroendocrine differentiation of castration resistant prostate cancer often occurs in a relevant subset of patients as a mechanism of resistance to androgen deprivation and androgen-receptor targeted drugs. Tumor cell plasticity toward neuroendocrine differentiation can be sustained …
-
Expression of epithelial and neuroendocrine markers within canine apocrine gland anal sac adenocarcinoma (AGASACA) and the relationship to peripheral hypercalcemia and parathyroid hormone-related protein (PTHrP) expression
… of these masses and identified evidence of neuroendocrine differentiation within some canine anal gland tumors. At this time, however, the significance of this finding is unknown, though additional examination may reveal relationships between neuroendocrine differentiation and the occurrence …
-
Investigating microRNA-375 as a Biomarker and Mechanistic Regulator in Neuroendocrine Neoplasms
Neuroendocrine neoplasms (NENs) are clinically and biologically diverse cancers with common morphological and molecular features. NENs require improved biomarkers for early diagnosis, and deeper understanding of molecular mechanisms driving pathogenesis. microRNAs (miRNAs) are small RNA regulatory …
-
Neuroendocrine neoplasms of the digestive tract: retrospective classification according to the 2019 WHO grading system, and evaluation of the immunohistochemical marker INSM1
Neuroendocrine Neoplasms (NENs) of the Gastrointestinal Tract (GIT) are a heterogeneous group of tumours with varied biologic potential and clinical outcomes. They are classified as well differentiated neuroendocrine tumours (WD NET) or poorly differentiated neuroendocrine carcinomas (PD NECs) …
-
Μελέτη ιστικών παραμέτρων για τη διάγνωση και την πρόγνωση όγκων με νευροενδοκρινή διαφοροποίηση
Tumors with a neuroendocrine differentiation (exclusively neuroendocrine or with a neuroendocrine component) are relatively rare entities and comprise a heterogeneous group because of the various localizations and histological phenotypes. Therefore, for many of these tumors there is lack of …
-
Arsenic, Cadmium And Neuron Specific Enolase (Enolase-2, Enolase-Gamma), Expression In Breast And Bladder Cancer
… has been used as a biomarker to help identify neuroendocrine differentiation in breast cancer. The next goal of the present study was to validate the microarray data and determine if ENO-2 expression in the breast epithelial cell is influenced by the environmental pollutants, As+3 or Cd+2, in …
-
Novel Mechanisms of Β-Adrenergic Signaling In Prostate Cancer Progression
… (CREB). Downstream targets of CREB activation in neuroendocrine differentiation as well as in neoangiogenesis are largely unknown, indicating that the underlying mechanisms of β-adrenergic signaling in prostate cancer progression are far from completely understood. For instance, while the …
-
Μελέτη του CD99 και άλλων νευροενδοκρινών δεικτών σε αδαμαντινοβλαστώματα
… These markers usually characterize neuroendocrine differentiation in neoplasms. For this purpose we applied immunohistochemical methods in paraffin embedded tissues. Results showed that ameloblastoma has a distinct immunohistochemical profile, similar to that of Ewing’s sarcoma/ …
-
Using Genome-Wide CRISPR/Cas9 Screens to Identify Novel Therapeutic Targets in Small Cell Lung Cancer
… The classical subtype of SCLC is noted for its neuroendocrine differentiation features. Standard treatment options have not improved in decades and SCLC tumors develop near universal rates of resistance to chemotherapy. This project aimed to elucidate novel therapies to SCLC using genome-wide …
-
Biological implications of leukocyte responsiveness to tumour-derived relaxin
… upregulated relaxin gene expression during neuroendocrine differentiation of the human prostate cancer model, LNCaP. To examine the impact of relaxin on host cells associated with adenocarcinomas, we generated recombinant 6 His-tagged relaxin (RLXH) in a mammalian expression system. This …
-
CaV1.3 Ion channel expression and hormone therapy in prostate cancer
… androgen-sensitive PCa and is associated with neuroendocrine differentiation. ENZ treatment promotes CaV1.3 plasma membrane localisation and functional expression in PCa subpopulations which may be worth therapeutic exploration.
-
The role of the ETS factor ELF3 in the normal and malignant prostate
… highlighted as a regulator of epithelial cell differentiation in other tissues. The overarching aim of this project was to elucidate the role of ELF3 in the context of both normal prostate development and prostate cancer. This study details an extensive expression profile of ELF3 in prostate …
-
Defining oncogenic determinants in prostate cancer initiation and progression
… to an AR-null state and the acquisition of neuroendocrine differentiation remain largely unknown. We have delineated critical roles of the pioneer factors ASCL1 and NEUROD1 in neuroendocrine transdifferentitation and uncovered their abilities to silence AR expression and signaling by …
-
The epithelial-mesenchymal transition protein periostin correlates with grading of neuroendocrine lung tumors
Background: Among neuroendocrine tumours (NET) of the lung, typical (TC) and atypical (AC) carcinoids represent the low, small cell lung carcinomas (SCLC) and large cell neuroendocrine carcinomas (LCNEC) the high grade spectrum. The N-glycoprotein periostin (POSTN) was recently found to be …
-
Διερεύνηση σχέσης μεταξύ των μηχανισμών των οδών MME/NPs και NFkB/πρωτεασώματος στον ανδρογονο-ανεξάρτητο καρκίνο του προστάτη (AIP)
… phenotype. Upregulation of NFB activity and neuroendocrine differentiation are two mechanisms known to be involved in prostate cancer progression to castration resistance. We investigated the interrelations of these pathways using in vitro models of androgen-dependent (AD) and …
-
Νευροενδοκρινής διαφοροποίηση του καρκίνου του προστάτη: Ο ρόλος των γλουταμικών υποδοχέων στα κύτταρα PC-3 (mGluR)
… Central Nervous System (CNS) in cancer cells. Neuroendocrine differentiation in prostate cancer is associated with the aggressive androgen independent prostate cancer. The neuroendocrine cells come of non neuroendocrine cells. They express receptors and secrete factors that act in paracrine way …
-
Προγνωστικοί παράγοντες υποτροπής εντοπισμένου ή τοπικοπεριοχικά προχωρημένου καρκινώματος προστάτη αδένα μετά από ριζική προστατεκτομή
… IHC status, growth factor IGF-1 Receptor IHCE, neuroendocrine differentiation (NED), assessed by Chromogranin A (Chr) IHCE & microvessel density (MVD), assessed by CD34 IHCE, in patients (pts) with localized prostate cancer (PC) after radical prostatectomy (RP).Patients & methods: Included in …
Page 1 of 2